ICU Medical director trades 2,424 shares, gets RSUs
ICU Medical director David C. Greenberg reported a mix of option exercises, stock sales, and equity awards.
Rhea-AI Filing Summary
ICU Medical director David C. Greenberg reported a mix of option exercises, stock sales, and equity awards. On May 12, 2026, he exercised options for 2,424 shares of common stock at $101.06 per share and sold 2,424 shares at $122.91 per share, leaving 7,960 shares held directly.
On May 13, 2026, 1,254 Restricted Stock Units vested into common stock, increasing his direct holdings to 9,214 shares. He also received a new grant of 1,475 Restricted Stock Units, which have no purchase or exercise price and will vest on the grant anniversary or the next annual stockholder meeting, whichever comes first.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
6 txns
Insider
Greenberg David C.
Role
Director
Sold
2,424 shs ($298K)
Approx. gross sale proceeds
$298K
Approx. exercise cost
$245K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Common Stock | 1,254 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,475 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,254 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) | 2,424 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,424 | $101.06 | $245K |
| Sale | Common Stock | 2,424 | $122.91 | $298K |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 0 contracts (Direct);
Common Stock — 1,475 contracts (Direct);
Common Stock — 9,214 shares (Direct)
Footnotes (4)
- F1. All shares sold were at the exact price disclosed.
- F2. These securities are Restricted Stock Units.
- F3. There is neither a purchase price nor an exercise price for the Restricted Stock Units.
- F4. These awards vest on the anniversary date of the date of the grant or the following annual stockholder meeting, whichever occurs first.
Key Figures
Shares sold: 2,424 shares
Sale price: $122.91/share
Options exercised: 2,424 shares
+4 more
7 metrics
Shares sold
2,424 shares
Open-market sale at $122.91 on May 12, 2026
Sale price
$122.91/share
Common stock sale of 2,424 shares on May 12, 2026
Options exercised
2,424 shares
Non-qualified stock option exercise at $101.06/share
Option exercise price
$101.06/share
Non-derivative exercise into 2,424 common shares
RSUs vested
1,254 units
Restricted Stock Units converting into common stock on May 13, 2026
New RSU grant
1,475 units
Restricted Stock Unit award on May 13, 2026
Shares held after transactions
9,214 shares
Common stock directly owned following May 13, 2026 activity
Key Terms
Non-Qualified Stock Option (right to buy), Restricted Stock Units, open-market sale, Exercise or conversion of derivative security
4 terms
Non-Qualified Stock Option (right to buy) financial
"security_title": "Non-Qualified Stock Option (right to buy)""
Restricted Stock Units financial
"These securities are Restricted Stock Units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Exercise or conversion of derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did ICUI director David C. Greenberg report?
David C. Greenberg reported option exercises, an open-market sale, and equity awards. He exercised options for 2,424 ICU Medical shares, sold 2,424 shares, had 1,254 Restricted Stock Units vest into stock, and received a new grant of 1,475 Restricted Stock Units.
What options did ICUI director David C. Greenberg exercise in this Form 4?
He exercised options for 2,424 shares of ICU Medical common stock at $101.06 per share. These options were represented as a non-qualified stock option, right to buy 2,424 underlying shares, which were fully exercised, leaving no remaining balance in that option grant.
What Restricted Stock Unit activity did ICUI report for the director?
The filing shows 1,254 Restricted Stock Units vesting into ICU Medical common stock and a new award of 1,475 Restricted Stock Units. The RSUs have no purchase or exercise price and vest on the grant anniversary or the next annual stockholder meeting, whichever occurs first.
Do the ICU Medical Restricted Stock Units in this Form 4 have an exercise price?
The Restricted Stock Units reported for Greenberg do not have a purchase or exercise price. Footnotes clarify there is neither a purchase price nor an exercise price for these RSUs, which convert into ICU Medical common stock upon vesting according to the award’s vesting schedule.
AI-generated analysis. How Rhea-AI works. Not financial advice.
